Lowering of oxidative stress in hemodialysis patients by dialysate cleaning: In relation to arteriosclerosis

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 4, 2004, Pages 313-319

  Oka, Yoshinari ^a   Miyazaki, Masashi ^a   Takatsu, Shigeko ^a   Kunitomo, Kei Ichi ^a   Kokumai, Yoshiaki ^a   Matsuda, Hiroaki ^b   Maruyama, Masanobu ^b  

^a Saiwai cho Memorial Hospital   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Arteriosclerosis; Endotoxin; Hemodialysis; Malondialdehyde low density lipoprotein; Oxidative stress; Oxidized low density lipoprotein

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL STIMULATION; CLEANING; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LIPID OXIDATION; MALE; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PURIFICATION;

ADULT; AGED; DIALYSIS SOLUTIONS; ENDOTOXINS; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS;

EID: 4243059498     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-0968.2004.00141.x     Document Type: Article

References (11)

1. Sanaka T, Nishikawa M, Suzuki T et al. Production of reactive oxygen metabolites during hemodialysis - A proposal of reactive oxygen metabolites hypothesis in patients under maintenance hemodialysis. Artif Organs Today 1991;1:129-34.
2. Tetta C, Biasioli S, Schiavon R, Inguaggiato P, David S, Panichi V. An overview of haemodialysis and oxidant stress. Blood Purif 1999;28:118-26.
3. Nakai S, Shinzato T, Sanaka T et al. An overview of dialysis treatment in Japan (as of December 31, 1999). J Jpn Soc Dial Ther 2001;34:1121-47.
4. Bazz M, Durand C, Ragon A et al. Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 1991;14:681-5.
5. Schwarwe S, Holzhauer M, Schaeffer J, Galanski M, Koch KM, Floege J. β2-microglobulin associated amyloidosis. A vanishing complication of long-term hemo-dialysis? Kidney Int 1997;52:1077-83.
6. Schmidt M, Baldamus CA, Schoeppe W. Backfiltration in hemodialysis with highly permeable membranes. Blood Purif 1984;2:108-14.
7. Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 1991;147:1567-74.
8. Nockher WA, Scherberich JE. Monocyte cell-surface CD14 antigen in hemodialysis: Evidence for chronic exposure to LPS. Kidney Int 1995;48:1469-76.
9. Tsimikas S, Witzum JL. Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. Circulation 2001;103:1930-2.
10. Ehara S, Ueda M, Naruko T et al. Elevated levels of oxidized low-density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001;103:1955-60.
11. Girndt M, Koul H, Sester U et al. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 2002;62:949-55.